Ascend Strategy
Search documents
Nordson(NDSN) - 2025 Q4 - Earnings Call Presentation
2025-12-11 13:30
4Q & FY Fiscal 2025 Webcast Agenda December 11, 2025 Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as "may," "will," "should," "could," "expects," "anticipates," "believes," "projects," "forecasts," "outlook," "guidance," "continue," "target," or the negative ...
Nordson Corporation Reports Record Fourth Quarter and Fiscal Year 2025 Results
Businesswireยท 2025-12-10 21:30
Core Insights - Nordson Corporation reported a 1% increase in fourth quarter sales for fiscal year 2025, reaching $752 million compared to $744 million in the previous year, influenced by favorable currency translation and acquisition impacts, but offset by a divestiture and organic sales decrease [1][2][4] - The company achieved a record net income of $152 million for the fourth quarter, translating to earnings per diluted share of $2.69, up from $122 million and $2.12 in the prior year [2][9] - Adjusted net income for the fourth quarter was $171 million, a 6.9% increase from $160 million in the previous year, with adjusted earnings per diluted share rising 9% to $3.03 [2][26] Financial Performance - EBITDA for the fourth quarter was $256 million, representing 34% of sales, an increase of 6% from $241 million or 32% of sales in the prior year [3][10] - For the full fiscal year 2025, total sales reached a record $2.8 billion, a 4% increase from the previous year, driven by a favorable acquisition impact of 6% despite a 3% decrease in organic volume [8][9] - Full-year EBITDA was $900 million, maintaining a margin of 32%, consistent with the previous year [10] Segment Performance - Industrial Precision Solutions sales decreased by 2% to $362 million, impacted by a 4% organic sales decline, while EBITDA remained stable at $137 million [5][17] - Medical and Fluid Solutions saw a 10% increase in sales to $220 million, with organic sales growth of 7% and EBITDA rising to $88 million, a margin increase of 380 basis points [6][18] - Advanced Technology Solutions experienced a 4% sales decline to $171 million, with EBITDA decreasing to $43 million, reflecting a margin drop [7][19] Outlook - The company enters fiscal 2026 with a backlog of approximately $600 million, a 5% increase from the prior year [12] - Sales for fiscal 2026 are projected to be between $2.83 billion and $2.95 billion, with adjusted earnings forecasted in the range of $10.80 to $11.50 per diluted share [13][14] - Management expressed optimism for solid growth in 2026, supported by the implementation of the Ascend Strategy and a focus on shareholder value through strategic capital deployment [14]